1-8 of 8
Wolfgang Kern
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characterization of cases with the rare cytogenetic abnormality i(7)(p10) reveals an association with IDH2-mutated AML

Anna Stengel, Katharina Hörst, Constanze Kühn, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Journal: Blood Advances
Blood Adv (2024) 8 (15): 4125–4128.
https://doi.org/10.1182/bloodadvances.2024013225
Published: 2024
Includes: Supplemental data
Journal Articles

The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing

Anna Maierhofer, Nikita Mehta, Ryan A. Chisholm, Stephan Hutter, Constance Baer, Niroshan Nadarajah, Christian Pohlkamp, Ella R. Thompson, Paul A. James, Wolfgang Kern, Claudia Haferlach, Manja Meggendorfer, Torsten Haferlach, Piers Blombery
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7346–7357.
https://doi.org/10.1182/bloodadvances.2023011389
Published: 2023
Includes: Supplemental data
Journal Articles

Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDS

Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5540–5548.
https://doi.org/10.1182/bloodadvances.2023010312
Published: 2023
Journal Articles

Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS

Anna Stengel, Torsten Haferlach, Constance Baer, Stephan Hutter, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
Journal: Blood Advances
Blood Adv (2023) 7 (13): 2952–2956.
https://doi.org/10.1182/bloodadvances.2022009100
Published: 2023
Includes: Supplemental data
Journal Articles

Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies

Anna Stengel, Constance Baer, Wencke Walter, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4426–4434.
https://doi.org/10.1182/bloodadvances.2021004668
Published: 2021
Includes: Supplemental data
Journal Articles

Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification

Clinical Trials & Observations
Inge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, Stephan Hutter, Constance Baer, Martijn Heymans, Peter J. M. Valk, Wolfgang Kern, Claudia Haferlach, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Jacqueline Cloos, Torsten Haferlach
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3254–3265.
https://doi.org/10.1182/bloodadvances.2021004556
Published: 2021
Includes: Supplemental data
Journal Articles

Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS

Anna Stengel, Rabia Shahswar, Torsten Haferlach, Wencke Walter, Stephan Hutter, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5393–5401.
https://doi.org/10.1182/bloodadvances.2020003007
Published: 2020
Includes: Supplemental data
Journal Articles

NPM1 mutated AML can relapse with wild-type NPM1 : persistent clonal hematopoiesis can drive relapse

Clinical Trials & Observations
Alexander Höllein, Manja Meggendorfer, Frank Dicker, Sabine Jeromin, Niroshan Nadarajah, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3118–3125.
https://doi.org/10.1182/bloodadvances.2018023432
Published: 2018